DEHP mediates drug resistance by directly targeting AhR in human breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DEHP mediates drug resistance by directly targeting AhR in human breast cancer

Published:2022-01 Issue: Volume:145 Page:112400
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Hsieh Tsung-Hua,Hsu Chia-Yi,Yang Pei-Jing,Chiu Chien-Chih,Liang Shih-Shin,Ou-Yang Fu,Kan Jung-Yu,Hou Ming-Feng,Wang Tsu-Nai,Tsai Eing-Mei

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference53 articles.

1. Breast cancer adjuvant therapy: time to consider its time-dependent effects;Jatoi;J. Clin. Oncol.,2011

2. Drug resistance in cancer: an overview;Housman;Cancers,2014

3. Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius;Arcamone;Biotechnol. Bioeng.,1969

4. Liposomal Doxorubicin in the treatment of breast cancer patients: a review;Lao;J. Drug Deliv.,2013

5. Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol;Olson;Proc. Natl. Acad. Sci. USA,1988

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure to endocrine disruptor DEHP promotes the progression and radiotherapy resistance of pancreatic cancer cells by increasing BMI1 expression and properties of cancer stem cells;Ecotoxicology and Environmental Safety;2024-09

2. Hazard identification of endocrine-disrupting carcinogens (EDCs) in relation to cancers in humans;Environmental Toxicology and Pharmacology;2024-08

3. An insight into carcinogenic activity and molecular mechanisms of Bis(2-ethylhexyl) phthalate;Frontiers in Toxicology;2024-07-23

4. StemRegenin-1 Reverses Drug Resistance of MCF-7/ADR Cells via AhR/ABC Transports and AhR/UGTs Pathways;Current Proteomics;2024-06

5. Exploring the bladder tissue microbiome in patients with muscle-invasive bladder cancer using 2bRAD-M sequencing;Oncologie;2024-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3